Getting Down to Business - January 29, 2025 episode artwork

EPISODE · Jan 29, 2025 · 3 MIN

Getting Down to Business - January 29, 2025

from Getting Down to Business · host Getting Down to Business

In this episode of Getting Down to Business, host Kadie DiGiuseppe goes over: - Novo Nordisk's Ozempic being approved to treat kidney disease in people with Type 2 diabetes. - Starbucks looking to make a comeback after its fiscal year results were announced. - 23andMe announcing it will be exploring alternatives after the company has faced a decline in sales.

In this episode of Getting Down to Business, host Kadie DiGiuseppe goes over: - Novo Nordisk's Ozempic being approved to treat kidney disease in people with Type 2 diabetes. - Starbucks looking to make a comeback after its fiscal year results were announced. - 23andMe announcing it will be exploring alternatives after the company has faced a decline in sales.

NOW PLAYING

Getting Down to Business - January 29, 2025

0:00 3:41

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Getting Down to Business?

This episode is 3 minutes long.

When was this Getting Down to Business episode published?

This episode was published on January 29, 2025.

What is this episode about?

In this episode of Getting Down to Business, host Kadie DiGiuseppe goes over: - Novo Nordisk's Ozempic being approved to treat kidney disease in people with Type 2 diabetes. - Starbucks looking to make a comeback after its fiscal year results...

Can I download this Getting Down to Business episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!